|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent ENT insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why ENT insider buys are important for investors to follow.
Date | Insider | Price | Amount |
11-21-2019 Insider Buy |
Joshua Marks Chief Executive Officer |
$0.45
CAGR »
|
$8,958.00 20,000 shares |
8-27-2019 Insider Buy |
Robert W. Reding Director |
$0.61
CAGR »
|
$15,250.00 25,000 shares |
8-19-2019 Insider Buy |
Ronald Steger Director |
$0.66
CAGR »
|
$33,000.00 50,000 shares |
6-5-2019 Insider Buy |
Ronald Steger Director |
$0.50
CAGR »
|
$100,500.00 200,000 shares |
6-7-2019 Insider Buy |
Jeffrey A. Leddy Executive Chairman |
$0.54
CAGR »
|
$216,000.00 400,000 shares |
6-5-2019 Insider Buy |
Searchlight II TBO-W, L.P. >10% Owner |
$0.30
CAGR »
|
$1,500,000.00 5,000,000 shares |
6-5-2019 Insider Buy |
Eric Louis Zinterhofer Director |
$0.30
CAGR »
|
$1,500,000.00 5,000,000 shares |
5-29-2019 Insider Buy |
Robert W. Reding Director |
$0.73
CAGR »
|
$14,600.00 20,000 shares |
5-23-2019 Insider Buy |
Per Noren President |
$0.85
CAGR »
|
$5,110.20 6,012 shares |
5-20-2019 Insider Buy |
Robert W. Reding Director |
$1.00
CAGR »
|
$25,000.00 25,000 shares |
5-20-2019 Insider Buy |
Harry Sloan Director |
$1.03
CAGR »
|
$5,356.00 5,200 shares |
5-17-2019 Insider Buy |
Jeffrey A. Leddy Executive Chairman |
$1.15
CAGR »
|
$57,500.00 50,000 shares |
5-17-2019 Insider Buy |
Joshua Marks Chief Executive Officer |
$1.09
CAGR »
|
$10,900.00 10,000 shares |
6-1-2018 Insider Buy |
Jeffrey Sagansky Director |
$2.38
CAGR »
|
$59,375.00 25,000 shares |
5-24-2018 Insider Buy |
Per Noren EVP, Chief Commercial Officer |
$1.96
CAGR »
|
$11,197.48 5,713 shares |
5-22-2018 Insider Buy |
Eric Sondag Director |
$1.81
CAGR »
|
$1,948,369.49 1,078,594 shares |
5-22-2018 Insider Buy |
Eric Louis Zinterhofer Director |
$1.81
CAGR »
|
$1,948,369.49 1,078,594 shares |
5-22-2018 Insider Buy |
Searchlight II TBO-W, L.P. >10% Owner |
$1.81
CAGR »
|
$1,948,369.49 1,078,594 shares |
5-18-2018 Insider Buy |
Joshua Marks Chief Executive Officer |
$1.25
CAGR »
|
$21,250.00 17,000 shares |
5-21-2018 Insider Buy |
Harry Sloan Director |
$1.59
CAGR »
|
$398,450.00 250,000 shares |
5-17-2018 Insider Buy |
Ronald Steger Director |
$1.02
CAGR »
|
$25,610.00 25,000 shares |
5-18-2018 Insider Buy |
Edward Shapiro Director |
$1.36
CAGR »
|
$135,810.00 100,000 shares |
5-18-2018 Insider Buy |
Harry Sloan Director |
$1.38
CAGR »
|
$345,275.00 250,000 shares |
5-18-2018 Insider Buy |
Eric Sondag Director |
$1.20
CAGR »
|
$683,002.80 568,800 shares |
5-18-2018 Insider Buy |
Eric Louis Zinterhofer Director |
$1.20
CAGR »
|
$683,002.80 568,800 shares |
5-17-2018 Insider Buy |
Robert W. Reding Director |
$1.00
CAGR »
|
$3.00 3 shares |
5-18-2018 Insider Buy |
Wale Adepoju EVP, Chief Strategy Officer |
$1.37
CAGR »
|
$25,324.65 18,500 shares |
5-17-2018 Insider Buy |
Jeffrey A. Leddy Executive Chairman |
$1.15
CAGR »
|
$100,927.20 88,000 shares |
5-17-2018 Insider Buy |
Joshua Marks Chief Executive Officer |
$1.08
CAGR »
|
$62,396.40 58,000 shares |
5-18-2018 Insider Buy |
Per Noren EVP, Chief Commercial Officer |
$1.36
CAGR »
|
$40,920.00 30,000 shares |
Also See: Institutional Holders of ENT
Also See: SEC filings
Below we present the annualized performance delivered by ENT stock since 11-21-2019 (the date of the most recent
insider purchase). The performance of the investment from the time ENT insider buying occurred is the ultimate
test of whether insiders were right about ENT being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
11/22/2019 |
|
End date: |
08/03/2020 |
|
Start price/share: |
$11.50 |
|
End price/share: |
$1.90 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-83.48% |
|
Annualized Gain: |
-119.96% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$1,652.00 |
|
Years: |
0.70 |
|
ENT Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent ENT insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding ENT
|
|